A carregar...
Arrhenius temperature dependence of in vitro tissue plasminogen activator thrombolysis
Stroke is a devastating disease and a leading cause of death and disability. Currently, the only FDA approved therapy for acute ischemic stroke is the intravenous administration of the thrombolytic medication, recombinant tissue plasminogen activator (tPA). However, this treatment has many contraind...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2040074/ https://ncbi.nlm.nih.gov/pubmed/17505082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1088/0031-9155/52/11/002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|